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During the last decade, the Caribbean Hispanic islands experienced accelerated
demographic aging, representing the fastest aging region within Latin America.
Age-related non-communicable diseases, including dementia, are now reported at high
prevalence. The Caribbean islands share similar genetic ancestry, culture, migration
patterns, and risk profiles, providing a unique setting to understand dementia in the
Caribbean-Hispanics. This perspective article aimed to describe the impact of dementia
in the Caribbean, at a local and regional level and reflect on research strategies to address
dementia. We report on 10/66 project findings, described research projects and regional
plans for the region. According to our results, the prevalence of dementia in the Caribbean
is the highest in Latin America, with 11.7% in Dominican Republic, 11.6% in Puerto
Rico, and 10.8% in Cuba. Preliminary data from new waves of the 10/66 study shows
increasing numbers of dementia cases. Furthermore, dementia is expected to be one
of the most serious medical and social issues confronted by Caribbean health systems.
However, there is a scarcity of knowledge, awareness, and health services to deal with
this public health crisis. In light of the new evidence, local and regional strategies are
underway to better understand dementia trends for the region and develop policies aimed
to decrease the impact of dementia. Implementation of our national plans is critical to deal
with an aging population with high dementia rates. Current recommendations include
emphasizing public health prevention campaigns to address modifiable risk factors and
expand support to caregiver and family interventions.
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INTRODUCTION
Epidemiological studies show a rapid increase in dementia in Hispanic populations (1, 2).
Approximately twelve percent of older adults in the Latino population are diagnosed with
Alzheimer’s Dementia (AD), representing the highest growing proportion of AD cases in any
ethnic group (3, 4). However, there is little to no understanding of disease onset, progression,
and biomarker trajectories in Latino populations (5). Furthermore, most of the AD studies tend to
include Latinos as a unique group, failing to sufficiently account for the real richness of linguistic,
ethnic, ancestry, cultural, and socioeconomic diversity represented across Latino communities.
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and social issues confronted by Caribbean health systems, with a
markedly elevated prevalence and incidence compared to other
Latin American countries in general (2).
Since 2003, the three islands in a coordinated effort led a
major epidemiological study (Figure 1) to determine dementia
prevalence, incidence, and impact across Caribbean countries
using a validated and standard methodology (13). The studies
were done under the umbrella of the 10/66 protocols (13), a
multinational research initiative aimed to provide a detailed
evidence to inform the development and implementation of
policies for improving the health and social welfare of older
people in low and middle income countries (14). The 10/66
studies encompass new methods to dementia research in
Low and Middle Income countries (LMIC) by developing a
novel approach to diagnosing dementia (the 10/66 Dementia
Diagnosis) and addressing difficulties in making diagnoses
among older people with little or no education and the use of
standardized protocols across all sites (13, 15). Although, the
10/66 study included several Latin America countries, India,
and China, in this perspective article we focus on the Hispanic
Caribbean studies. Further details of the 10/66 studies have been
described elsewhere (4, 16).
In the Caribbean region, the 10/66 project surveyed 6833
residents, aged 65 and over, in Cuba (n = 2813) and the
Dominican Republic (n = 2011) from 2003 to 2007, and in
Puerto Rico (n = 2009) from 2006 to 2008. The interviews
were done in a single phase, and the methodology allowed for
the diagnosis of dementia and its subtypes, as well as other
mental disorders. Data obtained included sociodemographic
characteristics, physical health, anthropometric measures;
information about risk factors, disability, frailty, utilization
of health services, income, lifestyle (including nutrition
and exercise), care characteristics, caregiver burden, and
genetic risk markers (including ApoE-4); implemented
together with a physical and neurological examination.
An interview with a reliable informant was required. An
incidence phase (second wave) was conducted 3 to 4 years after
cohort enrollment, 2007 to 2011. A third wave of the 10/66
protocol is currently underway (details of this new wave are
provided below).
The 10/66 studies in the Caribbean (Figure 1) have led
to several publications on the prevalence and incidence of
dementia and other chronic diseases (hypertension, stroke,
anemia, diabetes), the impact of dementia in terms of disability,
dependency, economic cost, care arrangements, and access
to services (17–20). We have focused our attention on
determinants of longitudinal outcomes, specifically incident
dementia, mortality, dependence, risk factors, and course of
dementia/ and Mild Cognitive Impairment. According to our
epidemiological studies, using the same methodology in all three
countries, the prevalence of dementia in individuals 65 years
old and over is ∼11.7% in DR, 11.6% in the PR, and 10.8%
in Cuba (Table 1). Preliminary data from a third wave of the
10/66 study suggest and in dementia prevalence relative to
previous waves, probably related to a higher frequency of vascular
risk factors and poor control of non-communicable diseases,
including hypertension, diabetes, etc. With this continuing trend,

In relation to other Latino populations, Caribbean-Hispanics
have several differences in customs, traditions, nutritional
patterns, risk behaviors, and genetic admixtures, which may
differentially impact the prevalence of dementia and expression
of its symptoms. Furthermore, during the last decade, the
Hispanic Caribbean islands (Cuba, Dominican Republic, and
Puerto Rico) experienced accelerated demographic aging,
representing the fastest aging region within Latin America,
which posed a unique challenge for aging and dementia
(6, 7). The Caribbean Hispanics represent 57.6% of the
Caribbean population (Cuba = 11,326,616, Dominican Republic
= 10,847,910, Puerto Rico = 3,193,694) region (6).
This perspective article aimed to examine the associations
of genetics and socioeconomic determinants with dementia and
describe the impact of dementia in the Hispanic Caribbean
islands at a local and regional level. In addition, we present
current research and describe future projects in the region.
Finally, we share current dementia strategies aimed to address
this epidemic within the Caribbean area.

AGING AND DEMENTIA IN THE
CARIBBEAN HISPANIC
The Caribbean is undergoing increasingly rapid population aging
with the proportion of older persons (60 and over) increasing
from 10% in 2000 to 14% in 2015, and projected to reach 25%
by 2050 (6). The rate of demographic aging is substantially faster
than occurred in western industrialized societies in the past
(8, 9). Consequently, compared to High-Income Countries, the
Caribbean region must adapt more quickly to aging populations,
posing a challenge to more fragile economies and less prepared
health care systems. Low fertility rates, a decrease in birth rate,
and increased life expectancy due to medical advancements are
the main factors related to the Caribbean’s aging phenomenon
(7). In addition, migration has played a unique role in the aging
process within the Caribbean Hispanic region; the three islands
have experienced extensive diasporas in the last century, with
these large migrations—primarily to the United States (US)—
establishing such well-known communities as Little Havana in
Miami, Hispanic Harlem, and Washington Heights, in New York
(10, 11). Recently, migration from PR to US increased after
Hurricanes Irma and Maria (Sept 2017). Migrants are often
young, and their departure has re-shape the population structure,
as a result the age structure of the population have change
significantly in the Caribbean islands.
As number and proportion of older persons increase, a central
question to the Caribbean region is whether the aging of this
population will be accompanied by sustained or improved health,
better quality of life, and sufficient social and economic resources.
To date, the increase in life expectancy has not been coupled
with improvements in lifestyle; risk behaviors such as consuming
high fat and carbohydrate diets, smoking, and sedentarism
are becoming more common. Likewise, population aging has
been associated with a sustained increase in non-communicable
diseases, including neurodegenerative disorders, like dementia
(2, 12). Dementia has become one of the most serious medical
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FIGURE 1 | Dementia in the Caribbean Hispanic Islands: Research Agenda, Figures, and Fact.

ten causes of death (4th-Puerto Rico, 6th-Cuba, 8th-Dominican
Republic) (23, 24). However, due to the relative lack of early
diagnosis and under registry on death certificates, current reports
are likely to be under estimated.
Finally, the total direct and indirect costs of dementia was
estimated to be 3.5 billion dollars, which is expected to double
in 20 years (22).
As mentioned earlier, a third wave of assessments using
an abbreviated form of the primary 10/66 survey is currently
underway, ∼10 years after the original baseline surveys (2016–
2020). For the new survey (third wave, n = 6000), we are
revisiting the original catchment areas to generate a revised
representative estimate of the prevalence of dementia for
the residents who are 65 years old or older; the updated
sample includes those individuals who, since the first wave
of the survey have been incorporated into the age group
of interest, either from having aged into it or from having
moved into the areas. The new, third-wave prevalence survey
includes a comprehensive assessment of health status, which
will consist of spirometry, body mass index, visual acuity,
grip strength, and tests to determine the presence of hearing
impairment (16). The new wave aim to determine the changes
in prevalence and incidence of dementia in the region and
its associated risk factors—emphasizing cardiovascular issues—
and to evaluate probable associations with APOE gene, markers
of inflamation and immunusenescence. Moreover, a nested
cohort of 300 individuals was randomly selected (150 with
a high risk of incident dependence and 150 without) aimed
to explore markers of frailty, including extensive laboratory
testing of frailty biomarkers. This sub-group will be followed 18
months later to re-assess vital status, needs for care, disability,

TABLE 1 | Caribbean Hispanics Islands population characteristics and 10/66
cohort profile.

Population Size, (No) millions

Cuba

Dominican
Republic

Puerto Rico

3.2

11.1

10.6

Over age 65, (%)

15

7

15

Life expectancy at birth (years)

80

74

80

Fertility rate (birth per woman)

1.7

2.4

1.1

2813

2011

2009

94

95

93

65-69

715 (25.5)

533 (26.5)

414 (20.6)

70-74

747(26.6)

520 (25.9)

456 (22.7)

75-79

618 (22.0)

396 (19.7)

483 (24.0)

>79

726 (25.9)

561 (27.9)

656 (12.0)

Gender (F), No (%)

1836 (65.3)

1325 (66)

1347 (67.3)

Dementia, No (%)

233 (11.6)

10/66 baseline characteristics
Participants, No
Response Rate (%)
Age (years), No (%)

292 (10.4)

235 (11.7)

Mild Cognitive Impairment, No (%)

42 (1.5)

26 (1.3)

68 (3.4)

Stroke, No (%)

216 (7.7)

175 (8.7)

168 (8.4)

1624 (57.9)

968 (48.6)

518 (32.1)

Hypertension, No (%)

by 2050, dementia in our countries may have one of the world’s
highest prevalence (with an estimated increase of 215%) (21, 22).
In the region, the main risk factors for dementia included:
older age, family history of dementia, and lower levels of
education. Poor cardiovascular health was associated with a
higher incidence rate (23). Dementia is also among the top

Frontiers in Public Health | www.frontiersin.org

3

January 2021 | Volume 8 | Article 611998

Acosta et al.

Dementia in Caribbean Hispanic Populations

cognitive function, and significant health-related life events in the
intervening period.

for family members of the PSEN1 families, as well as for sporadic
AD cases.

POPULATION ADMIXTURE, GENETICS,
AND CARIBBEAN HISPANICS

REGIONAL AND LOCAL POLICIES IN THE
CARIBBEAN

The Caribbean Hispanic population is highly multiethnic,
reflecting its complex colonial origins. Intermarriage between
diverse groups is widespread, and estimates of the percentage
of African descent people vary enormously, ranging from 34 to
62% (population genetic admixture includes mainly European
and African ancestry, with little contribution of Indigenous
ancestry) (25, 26). This genetic ancestry pattern is different
from the one described in South America, which includes
predominantly European and Indigenous populations (27).
The differences in genetics between the Caribbean-Hispanic
and non-Caribbean Hispanics may yield relevant information
regarding the influence of admixture background on dementia
risk. For example, the risk of AD associated with the APOE-ε4
allele has been found to vary according with African ancestry
proportions (28, 29).
According to our studies, the association between dementia
and APOE-ǫ4 is weaker in Caribbean Hispanics compared to
Caucasian populations. In the three Caribbean islands being
an APOE-ǫ4 carrier increases the risk to develop dementia by
two folds (SHR 2.03 [1.32-3.11]); in Caucasian populations the
risk among APOE-ǫ4 carriers is 10 to 15 times higher than in
non APOE-ǫ4 carriers (28, 30, 31). To date only 3% of genetics
studies in AD have been done in Hispanics population; (32,
33) like APOE-ǫ4, other genetic variants previously described
in Caucasians (e.g., TREM2, SORL1, ABCA7) may have a
differential risk among the Hispanic population; therefore the
influences of genetic risk factors in Caribbean Hispanics should
be explored in future studies.
The frequency of Dominantly Inherited Alzheimer disease
(DIAD) is relatively high in the Caribbean countries compare to
Europe and US; (33, 34) which can be attributable to common
ancestors causing a founder effect during early colonization
periods (35, 36). It is very likely that the establishment of
new colonies in the Caribbean islands combined with a high
degree of inbreeding among Caribbean populations (37) created
a reduced amount of genetic variation within the new population
settlements, influencing the spread of these mutations across the
islands. In Cuba, Bertoli et al. (38) described a novel Presenilin
1 (PSEN1) pathogenic variant (PSEN1_L174M) affecting several
families (280 family members) in the Cuban western provinces.
Furthermore, two decades ago, a family study was developed in
New York that included multiplex relatives affected with AD in
Dominican Republic and Puerto Rico, leading to the discovery
of novel PSEN1 pathogenic variant (PSEN1_G206A) (36). Since
2008, a new Early Onset AD study has been conducted in Puerto
Rico, leading to the discovery of 91 unrelated families featuring
this pathogenic variant. A total of 682 family members have been
evaluated and followed in one of the world’s biggest cohorts of
early-onset families (37, 39). Several studies, observational and
clinical trials with novel medications are ongoing in Puerto Rico

Education and Training in Dementia

Frontiers in Public Health | www.frontiersin.org

As mentioned early, the prevalence of dementia is high among
use Caribbean-Hispanics, yet knowledge, health services, and
awareness of the disease are scarce (40). Awareness and early
diagnosis are crucial elements to reduce dementia’s impact,
benefit patients and caregivers, and reduce treatment costs (41).
Early detection can prompt evaluation for reversible causes,
improve the care of comorbid illnesses, guide the selection of
appropriate symptomatic therapies, and identify the needs for
social support (41–43).
Unfortunately, cognitive impairment and dementia diagnosis
depend mostly on clinical suspicion, and ∼50% of dementia
cases are missed in primary care, delaying detection until
later in the disease course. Furthermore, awareness about
dementia diagnosis and care is not only relevant for health
care professionals, but also for the general population, especially
among those caring for someone with dementia; and these
are unmet needs in LMIC (44, 45). Consequently, there is a
current need to increase healthcare providers and caregivers’
training options.
Several local and regional strategies have been implemented
to address these issues. The Alzheimer’s Research Center in Cuba
has developed a multidisciplinary Master’s degree program to
improve early diagnosis, treatment, and support of people living
with dementia (46). Through this program, trainees will gain the
necessary knowledge to advance research on the dementia field
and provide better care to dementia patients and their families.
Similar strategies are underway in the Dominican Republic and
Puerto Rico. For example, the Department of mental health of
the Ministry of health in the Dominican Republic for the last 4
years has been training the primary care workforce in the mhGAP
intervention guide (47) with the aim that by 2025, at least 50%
of the estimated number of people with dementia will receive an
accurate diagnosis.
Another need is to expand the training of caregivers. The
regional Alzheimer Associations have led a caregiver awareness
program to improve caretaking abilities and expand caregivers’
support. A full training video-series featuring relevant topics
regarding caretaking in dementia and advice from health care
professionals are available to view and share free of charge.
“Conversando con Los Cuidadores”—new series in Spanishincludes eight videos focusing on critical issues related to the
work and role of those who provide care for relatives with
dementia. Training of caregivers will enhance their management
ability and enables them to handle disruptive situations. The
Dominican Alzheimer’s Association has been developing online
and on-site training sessions to support and decrease the burden
associated with caretaking. The 10/66 “Helping Caregivers to
Care, train-the-trainer” intervention was tested in a randomized
control trial in the DR, providing evidence on the relevance of
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with databases of Hispanic data collected in mainland USA,
including the Health and Retirement Study (HRS) and
Harmonized Cognitive Assessment Protocol (HCAP). In
addition, in collaboration with the Alzheimer’s Association,
several countries in the region will launch the LatAm FINGERS,
a multi-domain lifestyle intervention (diet and exercise), aimed
to improve cognitive function (48). This study will be conducted
from 2020 to 2022 and will recruit 1,300 participants from 13
countries in Latin America, including Argentina, Brazil, Bolivia,
Chile, Colombia, Costa Rica, Cuba, Dominican Republic,
Ecuador, Mexico, Paraguay, Peru, Puerto Rico, and Uruguay;
details of LatAm FINGERS has been described elsewhere (48).
Both CADAS and LatAm fingers projects show the relevance
of international collaboration to push regional and locals
research agendas.
To better understand disease pathology and AD progression
in Caribbean-Hispanics, a new Brain Bank is already in place
in DR, another one is being organized in PR. Our final goal
is to develop a Hispanic Caribbean Coordinating Center for
neuropathology sample collection and storage. To maintain
a coordinated research program, Caribbean researchers are
meeting several times per year, promoting the work’s continuity
and keeping the international collaborations. More recently, the
Ministry of Higher Education Science and Technology of the
Dominican Republic awarded the Brain Bank research funding
to expand research on AD pathology, with a special focus in Tau
patho-physiology. This project is a joint consortium with a local
university, “Pontificia Universidad Catolica Madre y Maestra”
and Universidad Autonoma de Mexico (UNAM).

caregiver training to decrease the burden associated with care.
This intervention continues to be widely used by the Dominican
Alzheimer’s Association to train caregivers (alz.co.uk/helpingcarers-to-care). The University of Puerto Rico, Geriatric’s
Education Center, offers specialized courses to train caregivers
in different sites, including a special arrangement with the
Dominican Republic Embassy in PR, to train Dominican
caregivers working in Puerto Rico. Likewise, there are multiple
caregiver training programs in private universities on the island.

LOCAL AND REGIONAL PLANS TO
ADDRESS DEMENTIA
In 2015, Cuba and the Alzheimer’s Research Center announced
the National plan for dementia, and it was adopted as a National
dementia strategy by the Cuban Ministry of health in 2016
(23). The main goals of the Cuban national strategy included:
1—Increase awareness, information, education, and support for
families; 2—Risk reduction (e.g., better control of cardiovascular
risk factors, reduce physical inactivity, promote healthy diets
among others); 3—Timely diagnosis and access to treatment; 4—
Improve care for dementia patients and their families; 5—Reduce
stigma around dementia; 6—Increase professional development
and train families for patient care; 7—Promote basic, clinical
and epidemiological research on dementia; 8—Familiarize health
teams with laws protecting the rights of older adults and
people with cognitive impairment; 9—Assess and improve the
quality of health care, social care, and long-term care support
and services. Furthermore, Cuba has taken the first steps in
implementing the Global action plan on the public health
response to dementia 2017–2025.
Similar to Cuba, in 2015, Puerto Rico launched the
Alzheimer’s disease Action Plan in response to the World Health
Organization’s (WHO) call to action, by rating AD and other
dementias as a public health priority. The focal areas of the
PLAN were divided into seven pillars: (1) Public Policy (2) Public
Health Efforts and Epidemiologic Surveillance (3) Home and
Community Caregiving Services (4) Education and Training (5)
Diagnosis and Treatment, (6) Long Term Care Services, and (7)
Long-Term Care Financing. Each area includes specifics goals to
be accomplished by 2025.
Finally, in July 2020, the Dominican Republic’s Ministry of
Public Health, in close partnership with Asociación Dominicana
de Alzheimer, announced a national strategy for dementia with
similar action points as Cuba and Puerto Rico. Future efforts in
the region are needed to achieve a coordinated response and plan
to address the rising number of dementia cases.

CONCLUSION
Dementia represents a challenge for public health in developing
countries with rapid demographic transitions, such as those
occurring in the Caribbean. We propose expanding our research
efforts to rural areas and explore gene by environment
interactions on dementia risk. Emphasis on genetic family
studies and admixture and new clinical trials with Hispanic
representation, should continue. The development of brain
banks and the implementation of biomarker studies are current
research priorities. Implementation of our national plans is
critical to deal with an aging population with high dementia rates,
ideally a true public health-focused approach should aim at social
change and emphasize on public-health prevention campaigns
directed to addressing modifiable risk factors and developing
caregiver and family interventions.
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